SNDX - Syndax Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2018-12-30
2017-12-30
2016-12-30
2015-12-30
Total Revenue
1,517
1,517
2,108
1,220
627
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
627
Operating Expenses
Research Development
49,312
60,106
48,201
31,665
9,549
Selling General and Administrative
14,872
17,287
15,861
13,321
11,591
Total Operating Expenses
64,184
77,393
64,062
44,986
21,140
Operating Income or Loss
-62,667
-75,876
-61,954
-43,766
-20,513
Interest Expense
-
-
-
-
1,575
Total Other Income/Expenses Net
-86
-27
-269
-1,662
-2,192
Income Before Tax
-60,884
-73,961
-60,802
-44,472
-24,119
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-60,884
-73,961
-60,802
-44,472
-24,119
Net Income
-60,884
-73,961
-60,802
-44,472
-24,119
Net Income available to common shareholders
-60,884
-73,961
-60,802
-47,070
-21,839
Reported EPS
Basic
-
-2.92
-2.90
-3.22
-2.28
Diluted
-
-2.92
-2.90
-3.22
-2.28
Weighted average shares outstanding
Basic
-
25,372
20,997
14,620
9,598
Diluted
-
25,372
20,997
14,620
9,598
EBITDA
-
-75,798
-61,878
-43,677
-22,523